These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 35436915)
1. Identification of novel prognostic targets in glioblastoma using bioinformatics analysis. Yin X; Wu Q; Hao Z; Chen L Biomed Eng Online; 2022 Apr; 21(1):26. PubMed ID: 35436915 [TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma. Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538 [TBL] [Abstract][Full Text] [Related]
3. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis. Chen X; Pan Y; Yan M; Bao G; Sun X Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990 [TBL] [Abstract][Full Text] [Related]
4. Multi-omics analysis predicts fibronectin 1 as a prognostic biomarker in glioblastoma multiforme. Kabir F; Apu MNH Genomics; 2022 May; 114(3):110378. PubMed ID: 35513291 [TBL] [Abstract][Full Text] [Related]
5. Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis. Yu C; Yin J; Wang X; Chen L; Wei Y; Lu C; You Y Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32412599 [TBL] [Abstract][Full Text] [Related]
6. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis. Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311 [TBL] [Abstract][Full Text] [Related]
7. Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Analyses. Wei X; Zhang QM; Liu C; Wu S; Nong WX; Ge YY; Lin LN; Li F; Xie XX; Luo B Curr Med Sci; 2022 Jun; 42(3):584-596. PubMed ID: 35678909 [TBL] [Abstract][Full Text] [Related]
8. Identification of Hub Gene GRIN1 Correlated with Histological Grade and Prognosis of Glioma by Weighted Gene Coexpression Network Analysis. Yang A; Wang X; Hu Y; Shang C; Hong Y Biomed Res Int; 2021; 2021():4542995. PubMed ID: 34840971 [TBL] [Abstract][Full Text] [Related]
9. PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma. Dong C; Fan W; Fang S J Mol Neurosci; 2020 Jan; 70(1):56-64. PubMed ID: 31617063 [TBL] [Abstract][Full Text] [Related]
10. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis. Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116 [TBL] [Abstract][Full Text] [Related]
11. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis. Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076 [TBL] [Abstract][Full Text] [Related]
12. Prediction and analysis of hub genes between glioblastoma and low-grade glioma using bioinformatics analysis. Xu B Medicine (Baltimore); 2021 Jan; 100(3):e23513. PubMed ID: 33545929 [TBL] [Abstract][Full Text] [Related]
13. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases. Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537 [No Abstract] [Full Text] [Related]
14. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion. Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the key prognostic genes and potential traditional Chinese medicine therapeutic targets in glioblastoma based on bioinformatics and network pharmacology methods. Xia Z; Gao P; Chen Y; Shu L; Ye L; Cheng H; Dai X; Hu Y; Wang Z Transl Cancer Res; 2022 May; 11(5):1386-1405. PubMed ID: 35706800 [TBL] [Abstract][Full Text] [Related]
16. Bioinformatics analysis of potential core genes for glioblastoma. Zhang Y; Yang X; Zhu XL; Hao JQ; Bai H; Xiao YC; Wang ZZ; Hao CY; Duan HB Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667033 [TBL] [Abstract][Full Text] [Related]
17. Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis. Chen B; Sun D; Qin X; Gao XH Invest New Drugs; 2021 Aug; 39(4):928-948. PubMed ID: 33501609 [TBL] [Abstract][Full Text] [Related]
18. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker. Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z Gene; 2019 May; 698():9-18. PubMed ID: 30825595 [TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data. Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134 [TBL] [Abstract][Full Text] [Related]
20. Non-negative matrix factorization and differential expression analyses identify hub genes linked to progression and prognosis of glioblastoma multiforme. Akçay S; Güven E; Afzal M; Kazmi I Gene; 2022 May; 824():146395. PubMed ID: 35283227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]